The Third Way
Achieving patient-centric transformation should be the ambition for any Big Pharma company. But it is a daunting and complex task. But maybe there is a way, one that helps identify and prioritise headline opportunities and threats posed by patient-centric transformation. One that takes weeks, not months, and doesn’t cost the earth. And one that enables you to take that first step early, and with confidence.